Food safety incidents can emerge without warning, requiring businesses to act swiftly to protect consumers and comply with regulatory obligations. Across Southeast Asia, Thailand, Vietnam, and Indonesia have each developed comprehensive food recall frameworks designed to ensure rapid removal of unsafe products from the market while holding businesses accountable for compliance failures. While these three jurisdictions share common objectives—protecting public health and ensuring food safety—each has crafted distinct regulatory approaches reflecting their unique administrative structures, enforcement priorities, and legal traditions. Understanding these differences is essential for food businesses operating in the region, as recall procedures, timelines, reporting requirements, and penalties vary significantly across borders. This guide, available through the button below, examines the food recall regulations in Indonesia, Thailand, and Vietnam, providing practical guidance on legal requirements, procedural steps, and compliance obligations in each market.

On November 13, 2025, Thailand’s Alcoholic Beverage Control Committee (ABCC) approved a draft announcement to lift the ban on the afternoon sale of alcohol for 180 days from the announcement’s effective date, which is expected to be in early December. Development of the draft was first set in motion when the cabinet approved economic stimulus measures on October 21, 2025. Subsequently, the Ministry of Public Health’s Department of Disease Control proposed revisions to alcohol sales hours to reduce operational constraints for tourism-facing businesses. The policy intent is to align rules for restaurant and café premises and retail operations with tourism demand while maintaining key public health guardrails. Change in Alcohol Sales Hours After the announcement takes effect, alcohol sales hours in Thailand will be changed in accordance with the table below, for a period of 180 days. What Remains Unchanged Midnight alcohol sales cutoff Advertising and marketing restrictions Seller duties (ID checks, intoxication assessment, licensing) Possibility of Extension The contemplated 180-day relaxation is targeted, time bound, and tailored to tourism recovery. It simplifies operational planning by eliminating the midday gap, enabling continuous service for lunch and late-afternoon sales across restaurants, cafés, bars, and other establishments. Data on the impact of the relaxation on tourism spending, public health indicators, and public order will be collected and sent to the ABCC for consideration of a possible extension beyond 180 days.

Attorneys in Tilleke & Gibbins’ regulatory affairs team have produced the Cannabis and Hemp Business Guide – Thailand, a primer on the rapidly developing cannabis industry in Thailand.

The Indonesian Food and Drug Administration (BPOM) has introduced more stringent oversight of health supplements containing probiotics with new guidelines that require clinical trials for certain products and expanded documentation standards. BPOM Regulation No. 17 of 2025 replaces the previous 2021 regulation and establishes a comprehensive framework for evaluating probiotic strains used in health supplements. Assessment Requirements The new regulation expands the scope of assessment to include not only categorization and documentation but also technical procedures, strain classification, and clinical trial requirements. Unlike the previous regulation, which provided general guidance, the updated framework creates a comprehensive system for evaluating both registered probiotic strains and new or combined strains. Manufacturers must now submit supporting documentation covering strain identification and functional characterization, safety, efficacy, and product quality. The previous regulation required documentation only on safety, efficacy, and quality. Clinical Trials One of the most significant changes is the requirement for clinical trials conducted in Indonesia for applications that include benefit claims other than maintaining digestive health, or where there are modifications to benefit claims. The regulation specifies that phase 1 trials must demonstrate safety, while phase 2 trials must validate efficacy using statistically valid methods such as double-blind, randomized, placebo-controlled studies). In addition, phase 3 and phase 4 trials may be required, and postmarket surveillance data must be submitted. Technical Assessment Framework Annex 4, a newly introduced section, establishes technical procedures for assessing health supplements containing probiotics in Indonesia. This comprehensive framework outlines criteria for evaluating new probiotic strains, including strain identification, functional characterization, safety, efficacy, and product quality. The annex introduces a clear classification of claims for health supplement products containing probiotics: General claims(e.g., maintaining digestive health). Functional claims(e.g., normal biological function or activity in the body). Risk reduction claims(e.g., lowering disease risk). The regulation restricts use of the term